Evidence item

MIT News independently reports AGENT’s high-temperature stability and comparable preclinical immune responses. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 18261

Source: New formulation helps RNA vaccines withstand high temperatures · locator {} · excerpt hash sha256:c5ce145914943575ebc1230061cd5637ee09f6940770b1381c9ea0e2bb871933

Exact excerpt

The researchers used a machine-learning algorithm to identify a formulation that keeps mRNA vaccines stable at 37 degrees Celsius for at least two months, while maintaining their ability to produce proteins. In tests in mice and nonhuman primates, the vaccines generated immune responses comparable to those generated by fresh vaccines.

Linked claims

Claim	Direction	Relevance	Steps	Counted
6dcdac63	SUPPORT	STRONG	0	yes

Audits

None.